Connection

William Hrushesky to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications William Hrushesky has written about Drug Administration Schedule.
William Hrushesky
Connection Strength
0.311
Drug Administration Schedule
  1. Larry Scheving and cancer chronotherapy. J Infus Chemother. 1995; 5(1):1-2.
    View in: PubMed
    Score: 0.027
  2. Biological perspectives on circadian cancer therapy. J Infus Chemother. 1995; 5(4):182-90.
    View in: PubMed
    Score: 0.027
  3. Circadian cancer therapy. J Clin Oncol. 1993 Jul; 11(7):1403-17.
    View in: PubMed
    Score: 0.025
  4. Circadian cancer pharmacodynamics. Ann Ist Super Sanita. 1993; 29(4):705-10.
    View in: PubMed
    Score: 0.024
  5. Reprogramming SynchroMed pumps: unanticipated inaccuracy. J Clin Oncol. 1991 Jun; 9(6):1089-90.
    View in: PubMed
    Score: 0.021
  6. Determination of the therapeutic index of floxuridine by its circadian infusion pattern. J Natl Cancer Inst. 1990 Mar 07; 82(5):386-93.
    View in: PubMed
    Score: 0.020
  7. Cancer chronotherapy: a drug delivery challenge. Prog Clin Biol Res. 1990; 341A:1-10.
    View in: PubMed
    Score: 0.019
  8. Circadian patterning of continuous floxuridine infusion reduces toxicity and allows higher dose intensity in patients with widespread cancer. J Clin Oncol. 1989 Nov; 7(11):1710-9.
    View in: PubMed
    Score: 0.019
  9. Control of a murine plasmacytoma with doxorubicin-cisplatin: dependence on circadian stage of treatment. J Natl Cancer Inst. 1989 Jan 18; 81(2):135-45.
    View in: PubMed
    Score: 0.018
  10. The rationale for non-zero-order drug delivery using automatic, computer-based drug delivery systems (chronotherapy). J Biol Response Mod. 1987 Dec; 6(6):587-98.
    View in: PubMed
    Score: 0.017
  11. Timing may be a critical factor in drug therapy. Cancer Treat Rep. 1987 Dec; 71(12):1321.
    View in: PubMed
    Score: 0.017
  12. High-dose intensity, circadian-timed doxorubicin and cisplatin adjuvant chemotherapy for bladder cancer. Cancer Treat Rep. 1987 Oct; 71(10):915-9.
    View in: PubMed
    Score: 0.017
  13. Circadian pattern of continuous FUDR infusion reduces toxicities. Prog Clin Biol Res. 1987; 227B:357-73.
    View in: PubMed
    Score: 0.016
  14. Chemotherapy-induced vomiting: circadian drug timing as a source of predictable within-patient variability. Cancer Treat Rep. 1986 Nov; 70(11):1347-8.
    View in: PubMed
    Score: 0.016
  15. Cisplatin chronotherapy and disulfiram rescue reduce toxicity without interfering with anticancer activity: animal findings and preliminary clinical experiences. Chronobiol Int. 1986; 3(1):55-64.
    View in: PubMed
    Score: 0.015
  16. Circadian timing of cancer chemotherapy. Science. 1985 Apr 05; 228(4695):73-5.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.